NYSE:ACAArcosa Stock Price, Forecast & News

Arcosa's stock was trading at $37.04 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ACA shares have increased by 23.5% and is now trading at $45.75.
View which stocks have been most impacted by Coronavirus.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Arcosa in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Arcosa.

Arcosa is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Arcosa.

Arcosa Inc (NYSE:ACA) posted its quarterly earnings data on Thursday, July, 30th. The company reported $0.73 earnings per share for the quarter, topping the consensus estimate of $0.60 by $0.13. The company had revenue of $498.50 million for the quarter, compared to the consensus estimate of $498.30 million. Arcosa had a net margin of 6.32% and a return on equity of 6.86%.
View Arcosa's earnings history.

Arcosa declared a quarterly dividend on Tuesday, May 5th. Shareholders of record on Wednesday, July 15th will be given a dividend of $0.05 per share on Friday, July 31st. This represents a $0.20 annualized dividend and a yield of 0.44%. The ex-dividend date of this dividend is Tuesday, July 14th.
View Arcosa's dividend history.

4 equities research analysts have issued 1 year price objectives for Arcosa's shares. Their forecasts range from $48.00 to $61.00. On average, they expect Arcosa's stock price to reach $53.00 in the next year. This suggests a possible upside of 15.8% from the stock's current price.
View analysts' price targets for Arcosa.

News headlines about ACA stock have trended very positive on Friday, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Arcosa earned a news sentiment score of 4.0 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near term.
View the latest news about Arcosa.

Arcosa saw a decline in short interest during the month of July. As of July 31st, there was short interest totaling 691,400 shares, a decline of 8.1% from the July 15th total of 752,000 shares. Based on an average trading volume of 333,900 shares, the short-interest ratio is presently 2.1 days. Currently, 1.5% of the company's stock are sold short.
View Arcosa's Current Options Chain.

Some companies that are related to Arcosa include Deere & Company (DE), AGCO (AGCO), Alamo Group (ALG), Lindsay (LNN) and Arts-Way Manufacturing (ARTW).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Arcosa investors own include Walt Disney (DIS), AbbVie (ABBV), AT&T (T), NVIDIA (NVDA), Trinity Industries (TRN), Netflix (NFLX), Xilinx (XLNX), Applied Materials (AMAT), Advanced Micro Devices (AMD) and Alibaba Group (BABA).

Arcosa trades on the New York Stock Exchange (NYSE) under the ticker symbol "ACA."

Arcosa's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Copper Rock Capital Partners LLC (37.27%), Yacktman Asset Management LP (0.85%), Russell Investments Group Ltd. (0.79%), Principal Financial Group Inc. (0.77%), Emerald Advisers LLC (0.50%) and Emerald Mutual Fund Advisers Trust (0.40%). Company insiders that own Arcosa stock include Antonio Carrillo, Kerry S Cole, Ronald J Gafford and Valueact Capital Master Fund,.
View institutional ownership trends for Arcosa.

ACA stock was sold by a variety of institutional investors in the last quarter, including WINTON GROUP Ltd, Russell Investments Group Ltd., UBS Group AG, Bessemer Group Inc., First Trust Advisors LP, Yacktman Asset Management LP, Raymond James & Associates, and Principal Financial Group Inc.. Company insiders that have sold Arcosa company stock in the last year include Kerry S Cole, and Ronald J Gafford.
View insider buying and selling activity for Arcosa.

ACA stock was bought by a variety of institutional investors in the last quarter, including Copper Rock Capital Partners LLC, Dalton Greiner Hartman Maher & Co., Mutual of America Capital Management LLC, Great Lakes Advisors LLC, Swiss National Bank, Emerald Mutual Fund Advisers Trust, Aptus Capital Advisors LLC, and SG Americas Securities LLC.
View insider buying and selling activity for Arcosa.

Shares of ACA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of ACA stock can currently be purchased for approximately $45.75.

Arcosa has a market capitalization of $2.21 billion and generates $1.74 billion in revenue each year. The company earns $113.30 million in net income (profit) each year or $2.35 on an earnings per share basis. Arcosa employs 6,275 workers across the globe.

The official website for Arcosa is www.arcosa.com.

Arcosa's mailing address is 500 N. Akard Street Suite 400, DALLAS TX, 75201. The company can be reached via phone at 972-942-6500 or via email at [email protected]